XML 120 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
EARNINGS PER SHARE
12 Months Ended
Jan. 03, 2015
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
EARNINGS PER SHARE

The following is a reconciliation of basic common shares outstanding to diluted common and common equivalent shares outstanding:
 
For the fiscal years ended
 
January 3,
2015
 
December 28,
2013
 
December 29,
2012
Weighted-average number of common and common equivalent shares outstanding:
 
 
 
 
 
Basic number of common shares outstanding
52,614,425

 
56,931,216

 
58,217,503

Dilutive effect of equity awards
479,114

 
590,951

 
851,684

Diluted number of common and common equivalent shares outstanding
53,093,539

 
57,522,167

 
59,069,187

 
 
 
 
 
 
Earnings per share:
 
 
 
 
 
(dollars in thousands, except per share data)
 
 
 
 
 
 
 
 
 
 
 
Basic net income per common share:
 
 
 
 
 
Net income
$
194,670

 
$
160,407

 
$
161,150

Income allocated to participating securities
(2,586
)
 
(2,144
)
 
(2,095
)
Net income available to common shareholders
$
192,084

 
$
158,263

 
$
159,055

 
 
 
 
 
 
Basic net income per common share
$
3.65

 
$
2.78

 
$
2.73

 
 
 
 
 
 
Diluted net income per common share:
 
 
 
 
 
Net income
$
194,670

 
$
160,407

 
$
161,150

Income allocated to participating securities
(2,568
)
 
(2,126
)
 
(2,072
)
Net income available to common shareholders
$
192,102

 
$
158,281

 
$
159,078

 
 
 
 
 
 
Diluted net income per common share
$
3.62

 
$
2.75

 
$
2.69

 
 
 
 
 
 
Anti-dilutive shares excluded from dilutive earnings per share calculations (1)
230,150

 
355,900

 
613,000


(1) The volume of antidilutive shares is, in part, due to the related unamortized compensation costs.

In connection with the 2013 ASR Agreements discussed in the common stock footnote, the Company received one million additional shares in January 2014 for a total of approximately 5.6 million shares during fiscal 2014 and 2013 under the ASR program. The shares were retired upon receipt and, accordingly, reduced the Company's weighted average shares outstanding for purposes of the calculation of earnings per share.

The Company evaluated the ASR Agreements for their potential dilution of earnings per share and determined, for all periods impacted by the ASR Agreements, that the Company would not have been required to deliver additional shares to JPMorgan based on the volume-weighted average prices calculated for all impacted periods. The Company determined that these shares would have had an anti-dilutive effect and excluded these shares from the diluted earnings per share calculation for all periods.